198 results on '"Franke, Christiana"'
Search Results
2. Randomized controlled double-blind trial of methylprednisolone versus placebo in patients with post-COVID-19 syndrome and cognitive deficits: study protocol of the post-corona-virus immune treatment (PoCoVIT) trial
3. IA-PACS-CFS: a double-blinded, randomized, sham-controlled, exploratory trial of immunoadsorption in patients with chronic fatigue syndrome (CFS) including patients with post-acute COVID-19 CFS (PACS-CFS)
4. Cognitive decline in post-COVID-19 syndrome does not correspond with persisting neuronal or astrocytic damage
5. Characteristic functional connectome related to Post-COVID-19 syndrome
6. Cerebrospinal fluid findings in patients with neurological manifestations in post-COVID-19 syndrome
7. Neurological symptoms after COVID-19 vaccination: a report on the clinical presentation of the first 50 patients
8. Multidomain cognitive impairment in non-hospitalized patients with the post-COVID-19 syndrome: results from a prospective monocentric cohort
9. Structural brain changes in patients with post-COVID fatigue: a prospective observational study
10. Manifestationen im Zentralnervensystem nach COVID-19
11. Intravenous immunoglobulins for treatment of severe COVID-19-related acute encephalopathy
12. Delirium on stroke units: a prospective, multicentric quality-improvement project
13. Anti-neuronal antibodies against brainstem antigens are associated with COVID-19
14. Sequential treatment of progressive multifocal leukoencephalopathy with intravenous immunoglobulins and pembrolizumab
15. Neurological manifestations of post-COVID-19 syndrome S1-guideline of the German society of neurology
16. Risk Factors for Postoperative Delirium Severity After Deep Brain Stimulation Surgery in Parkinson's Disease.
17. Neurologische Langzeitfolgen von COVID-19.
18. High serum prevalence of autoreactive IgG antibodies against peripheral nerve structures in patients with neurological post-COVID-19 vaccination syndrome.
19. Altered brain perfusion and oxygen levels relate to sleepiness and attention in post‐COVID syndrome.
20. Performance evaluation of automated white matter hyperintensity segmentation algorithms in a multicenter cohort on cognitive impairment and dementia
21. Welche prädisponierenden Risiken beeinflussen die Entstehung eines Delirs in der akutstationären Behandlung im Krankenhaus? – Eine Sekundärdatenanalyse
22. Left frontal hub connectivity delays cognitive impairment in autosomal-dominant and sporadic Alzheimer’s disease
23. Neurologische Langzeitfolgen von COVID-19
24. Neuroimmunologie von COVID‑19
25. The BDNFVal66Met SNP modulates the association between beta-amyloid and hippocampal disconnection in Alzheimer’s disease
26. Cerebrospinal fluid findings in patients with neurological manifestations in post-COVID-19 syndrome
27. Störungen der Basalganglienfunktion
28. Adressen
29. Management of delirium in Parkinson’s disease
30. Subjective and Objective Cognitive Deficits in Patients with Post-COVID Syndrome
31. Validation of two nurse-based screening tools for delirium in elderly patients in general medical wards
32. Association of cerebrospinal fluid brain-binding autoantibodies with cognitive impairment in post-COVID-19 syndrome
33. A Managed Care System with Telemedicine Support for Neurological Emergencies
34. Multidomain cognitive impairment in non-hospitalized patients with the post-COVID-19 syndrome: results from a prospective monocentric cohort
35. Nonmotor Fluctuations in Parkinson's Disease
36. Cerebrospinal Fluid Analysis Post–COVID-19 Is Not Suggestive of Persistent Central Nervous System Infection
37. Vaccine-Induced Thrombocytopenia with Severe Headache
38. Cerebrospinal Fluid Analysis Post–COVID ‐19 Is Not Suggestive of Persistent Central Nervous System Infection
39. Neurological symptoms and complications in predominantly hospitalized COVID-19 patients: Results of the European multinational Lean European Open Survey on SARS-Infected Patients (LEOSS)
40. A Neurological Outpatient Clinic for Patients With Post-COVID-19 Syndrome — A Report on the Clinical Presentations of the First 100 Patients
41. High frequency of cerebrospinal fluid autoantibodies in COVID-19 patients with neurological symptoms
42. Letter to the Editor: Comment on Mulder J et al. (2021) indirect immunofluorescence for detecting anti-neuronal autoimmunity in CSF after COVID-19 – possibilities and pitfalls
43. A Neurological Outpatient Clinic for Patients With Post-COVID-19 Syndrome ��� A Report on the Clinical Presentations of the First 100 Patients
44. Neuro-COVID-19 is more than anosmia: clinical presentation, neurodiagnostics, therapies, and prognosis
45. Neurological symptoms and complications in predominantly hospitalized COVID-19 patients: Results of the European multinational Lean European Open Survey on SARS-Infected Patients (LEOSS)
46. Neuro-COVID-19 is more than anosmia: clinical presentation, neurodiagnostics, therapies, and prognosis
47. Minor neuropsychological deficits in patients with subjective cognitive decline
48. Stroke Admissions, Stroke Severity, and Treatment Rates in Urban and Rural Areas During the COVID-19 Pandemic
49. Fampridine and Acetazolamide in EA2 and Related Familial EA
50. A Therapeutic Non-self-reactive SARS-CoV-2 Antibody Protects from Lung Pathology in a COVID-19 Hamster Model
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.